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The activities of five fluorinated 4-quinolones, namely, sarafloxacin, enrofloxacin, PD127391, PD117596, and
C1934, against the fish pathogen Aeromonas salmonicida were investigated and compared with that of oxolinic
acid. The results indicated that with the exception of C1934, these drugs are more active than oxolinic acid in
terms of MIC. No inoculum effect was observed, but the drugs were less active at 10°C than at 22°C. The
presence of 3% NaCl caused an increase in drug activity. Resistance to the drugs appeared to be fairly stable,
with only a small decrease in activity after 10 successive passages of the test strains on drug-free tryptone soya
agar.
Aeromonas salmonicida is the causative agent of furuncu-
losis, one of the most destructive bacterial diseases of
farmed salmonid fish (8). As yet, a suitable vaccine against
the disease is not available, and control of furunculosis is
still dependent upon the use of antibiotics. Currently, con-
ventional therapy for furunculosis consists of oxytetracy-
cline, potentiated sulfonamide, or, more usually, oxolinic
acid (3, 5). However, oxolinic acid therapy in fish farming
has been compromised by the development of resistant
strains of A. salmonicida (1, 6). Recent work has suggested
that some of the new fluorinated 4-quinolones, including
enrofloxacin-which is already licensed for veterinary
use-may be more effective in the treatment of A. salmoni-
cida infections in fish than the current regimen of oxolinic
acid (4, 7, 9, 13, 14; C. S. Lewin and T. S. Hastings, J. Fish
Dis., in press).
In this investigation, the in vitro activities of five
fluoroquinolones-enrofloxacin (Bayer, United Kingdom),
sarafloxacin (A-56620) (Abbott Laboratories, North Chi-
cago, 11.), C1934, PD117596, and PD127391 (all from Parke-
Davis, Basingstoke, United Kingdom)-were compared
with that of oxolinic acid (Sigma Chemical Co., Poole,
United Kingdom).
MICs of each drug were determined for 38 oxolinic
acid-resistant and 45 oxolinic acid-susceptible strains of A.
salmonicida isolated primarily from outbreaks of furunculo-
sis at Scottish salmon farms. By using the criteria proposed
by Tsoumas et al. (14), strains for which the MIC of oxolinic
acid was less than 1.0 ,ug/ml were deemed oxolinic acid
susceptible, whereas strains for which the MIC was greater
than or equal to 1.0 ,ug/ml were deemed oxolinic acid
resistant. Stock cultures were stored in tryptone soya broth
(Oxoid Ltd., London, England) plus 10% glycerol at -70°C.
MICs were determined by the agar dilution technique on
tryptone soya agar (Oxoid) by employing an arithmetic
dilution scheme devised by Smith (11). The antibiotic plates
were inoculated with 105 CFU per spot by using a multipoint
inoculator (Denley, Billingshurst, United Kingdom). The
plates were incubated aerobically overnight at 22°C in a
cooled incubator (Gallenkamp, Loughborough, United
Kingdom), unless otherwise stated. The MIC was defined as
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the lowest concentration at which growth was completely
inhibited.
On average, PD117596 and PD127391 were at least 15
times more active, in terms of MIC, than oxolinic acid
against oxolinic acid-resistant strains and 10 times more
active against oxolinic acid-susceptible strains. Both sara-
floxacin and enrofloxacin were slightly more active than
oxolinic acid against both oxolinic acid-resistant and oxo-
linic acid-susceptible strains. For the oxolinic acid-resistant
isolates of A. salmonicida, MICs of enrofloxacin were up to
5 ,ug/ml, while the highest MIC of enrofloxacin reported by
Tsoumas et al. (14) was 0.5 ,ug/ml. C1934 was as active as
oxolinic acid against resistant strains but less active against
susceptible strains (Table 1).
The effect of inoculum size on the activities of the drugs
was assessed for three oxolinic acid-susceptible and three
oxolinic acid-resistant strains of A. salmonicida. MICs were
determined by plate technique as described above with
inocula of 106, 104, and 102 CFU per spot. The maximum
change in MIC with inoculum size was found to be approx-
imately threefold (1.5 to 5 pug/ml). However, considering the
10,000-fold increase in cell concentration, a 3-fold increase
in MIC seems insignificant.
The MIC of each drug for 18 oxolinic acid-susceptible
strains was also determined at 10°C, since outbreaks of
furunculosis frequently occur at this temperature. Results
were read after 5 and 7 days of incubation at 10°C. There was
a two- to threefold increase in MIC at 10°C after both 5 and
7 days of incubation, compared with the MICs at 22°C.
Ion concentrations can affect the activities of the quinolo-
nes (12). The effect of salinity on the MICs was therefore
investigated with seven oxolinic acid-susceptible strains of
A. salmonicida. MICs were determined in the presence of
3% NaCl (wt/vol), which is approximately the average
salinity of seawater (2, 10). After both 5 and 7 days of
incubation at 22°C, there was an overall decrease in MIC
compared with the MICs for strains tested in the absence of
added salt. In the cases of sarafloxacin, enrofloxacin,
PD127391, and oxolinic acid, there was a mean threefold
decrease for each. However, PD117596 showed a mean
15-fold decrease, whereas the activity of CI934 was barely
affected.
It has recently been reported that resistance of A. salmo-
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TABLE 1. In vitro activities of 4-quinolones against 83 A. salmonicida strains
MIC at 22°C (p.g/ml)a
Strain type (no. of isolates) Test agent
50% 90% Range
Oxolinic acid resistant (38) Oxolinic acid 3.00 7.50 1.00-15.00
Sarafloxacin 1.50 4.00 0.20-4.00
Enrofloxacin 0.50 1.00 0.05-5.00
C1934 3.00 7.50 0.30-10.00
PD127391 0.10 0.15 0.015-0.30
PD117596 0.15 0.50 0.075-0.75
Oxolinic acid susceptible (45) Oxolinic acid 0.03 0.40 0.01-0.75
Sarafloxacin 0.05 0.20 0.0075-1.00
Enrofloxacin 0.02 0.15 0.004-0.75
C1934 0.40 1.00 0.04-3.00
PD127391 0.0075 0.03 0.002-0.10
PD117596 0.015 0.05 0.003-0.50
a 50% and 90%, MIC for 50 and 90% of isolates tested, respectively.
nicida to oxolinic acid is reduced after repeated passage on
tryptone soya agar medium (14). After 10 successive pas-
sages of 20 oxolinic acid-resistant strains of A. salmonicida
on drug-free tryptone soya agar, there was a mean threefold
decrease in the MIC of oxolinic acid. However, no such
decrease was observed for PD117596, PD127391, or sara-
floxacin, whereas a twofold decrease in MIC was noted for
enrofloxacin and C1934. Despite the threefold decrease in
MIC observed for oxolinic acid, all strains are still classified
as resistant by the criteria of Tsoumas et al. (14), and hence
the significance of such a small change must be questioned.
In conclusion, PD117596, PD127391, sarafloxacin, and
enrofloxacin are at least as active, in terms of MIC, as
oxolinic acid against oxolinic acid-susceptible organisms.
However, all four of these drugs, but particularly PD117596
and PD127391, were considerably more active than oxolinic
acid against the oxolinic acid-resistant strains. There was no
inoculum effect on the MICs of the drugs, and drug resis-
tance tended to be fairly stable, with only small changes in
MIC after 10 successive passages on drug-free tryptone soya
agar. However, at 10°C, at which temperature outbreaks of
furunculosis in salmon are not unusual, an increase in MIC
was observed for all drugs. Nevertheless, with the exception
of CI934, the MICs of all drugs remained well below 1.0
,ug/ml. The apparent increase in activity of the drugs in the
presence of NaCl contrasts with results obtained for other
bacterial species, for which the MICs of fluoroquinolones
were unaffected by Na+ ion concentration (12). These re-
sults, combined with evidence that fluoroquinolones may be
more bactericidal than oxolinic acid (Lewin and Hastings, in
press), suggest that further investigations with these agents
are required, since the drugs may represent a potential
advance in the treatment and control of furunculosis.
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